ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.58
+0.42 (1.90%)
Mar 9, 2026, 4:00 PM EDT - Market closed

ACADIA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,8504,5493,0595,1552,5803,758
Market Cap Growth
15.97%48.70%-40.66%99.81%-31.34%-55.96%
Enterprise Value
3,0823,7702,3454,7642,2163,293
Last Close Price
22.5826.7118.3531.3115.9223.34
PE Ratio
9.8211.6113.49-84.62-11.88-22.23
Forward PE
45.4840.3835.9027.40--
PS Ratio
3.594.253.197.104.997.76
PB Ratio
3.133.714.1711.946.446.95
P/TBV Ratio
3.133.704.1711.886.436.93
P/FCF Ratio
36.6143.2619.46309.58-22.63-29.64
P/OCF Ratio
35.0541.4219.40308.66-22.63-29.91
EV/Sales Ratio
2.883.522.456.564.286.80
EV/EBITDA Ratio
26.4432.349.51-70.24-9.91-19.71
EV/EBIT Ratio
29.4135.9710.16-64.93-9.91-19.32
EV/FCF Ratio
29.3135.8514.92286.10-19.43-25.98
Debt / Equity Ratio
0.030.030.060.110.130.10
Debt / EBITDA Ratio
0.350.350.17-0.70-0.24-0.34
Debt / FCF Ratio
0.390.390.272.87-0.46-0.44
Net Debt / Equity Ratio
-0.63-0.63-0.97-0.91-0.91-0.86
Net Debt / EBITDA Ratio
-6.68-6.68-2.895.771.632.78
Net Debt / FCF Ratio
-7.41-7.41-4.54-23.483.193.66
Asset Turnover
0.780.780.991.090.800.65
Inventory Turnover
3.143.142.831.961.402.18
Quick Ratio
3.493.492.182.133.826.10
Current Ratio
3.833.832.382.424.046.43
Return on Equity (ROE)
39.89%39.89%38.89%-14.73%-45.89%-28.75%
Return on Assets (ROA)
21.44%21.44%20.91%-13.18%-35.13%-23.04%
Return on Invested Capital (ROIC)
117.01%117.01%436.78%-174.15%-351.57%-266.79%
Return on Capital Employed (ROCE)
10.08%10.08%35.85%-15.34%-41.94%-26.62%
Earnings Yield
10.16%8.61%7.41%-1.18%-8.42%-4.50%
FCF Yield
2.73%2.31%5.14%0.32%-4.42%-3.37%
Buyback Yield / Dilution
-1.10%-1.10%-0.22%-0.49%-0.32%-0.48%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q